reLink Medical wins patent for AI engine behind equipment pricing platform

reLink Medical secured a U.S. patent covering the AI engine that powers its disposition workflow and reLink Intelligence market data platform. The company says the system evaluates more than 13,000 devices a month and turns those outcomes into valuation data for hospitals, manufacturers, GPOs and insurers.

Why it matters: - reLink Medical says the patent protects the core engine that drives both equipment disposition decisions and valuation inside reLink Intelligence. - The platform is meant to replace weak secondary-market evidence with transaction-based pricing data for hospitals, manufacturers, group purchasing organizations and insurers. - The system matters because medical equipment value has often been estimated from list prices, anecdotal quotes and asking prices rather than completed sales.

What happened: - reLink Medical was awarded U.S. Patent No. 12,683,018, "Reverse Supply Chain Gateway for Medical Equipment." - The patent was filed in February 2024 and issued July 14, 2026. - The patent covers the reFramer™ AI Econometric Evaluation Engine, which sits at the center of reLink Medical's disposition operation and powers reLink Intelligence™. - The company said reFramer™ evaluates every piece of equipment it receives and helps determine whether a device should move to resale, redeployment, donation or responsible recycling.

The details: - reFramer stands for Repurpose Econometrics For Rapidly Analyzing Medical Equipment Reuse. - The engine uses image processing and AI to identify equipment and decide whether more photography, testing or research is worth the cost. - reLink Medical makes that decision more than 13,000 times a month, and the patent covers that workflow. - Each decision creates a verified, outcome-linked record showing what the device was, its condition and what it actually sold for. - Ten years of those records power reLink Intelligence, where the same engine scores current value against outcomes it produced and verified itself. - The system also weighs current market conditions and the relative costs of end-of-life options. - reLink Intelligence draws on more than 2.4 million equipment data points, 120,000 devices, 12,000 tracked buyer profiles and more than 400 modality and manufacturer combinations. - The dataset was built from more than 3,000 hospitals over 10 years. - The platform provides fair-market valuation benchmarks by modality, manufacturer, model and condition. - The platform also offers lifecycle signals, peer benchmarking, demand analytics and custom data partnerships. - reLink Medical says the data can support hospital capital planning, replacement decisions, manufacturer trade-in strategy, GPO negotiations and insurance claims valuation.

Between the lines: - The patent claim gives reLink Medical a formal moat around a process the company says is already embedded in daily operations. - The business model depends on a closed feedback loop: the same system that decides disposition also learns from completed transactions and uses those outcomes to price future equipment. - That approach is designed to be stronger than datasets assembled only from listings, because the company says those sources cannot verify final transaction outcomes.

What's next: - reLink Intelligence is available now. - The company is directing more information and partnership inquiries to reLink Medical's intelligence page. - reLink Medical says manufacturers and institutional partners can get structured access to relevant slices of the dataset through custom data partnerships.

The bottom line: - reLink Medical is turning its disposition workflow into a patented data engine, with pricing power built from the company’s own verified equipment-sale history.